Filters applied:
Did You Mean? ?
one result

 

  • Book
    Alan S. Maisel, Allan S. Jaffe, editors.
    Digital : Springer2016
    Part I. Ischemic Heart Disease -- 1. Pre-analytical factors and analytical issues affecting interpretation of cardiovascular biomarkers -- 2. Troponin basics for clinicians -- 3. Unique aspects of high sensitivity assays: what are they, why do we need them, and how do we use them? -- 4. Evaluation of patients presenting with chest pain in the emergency department: where do troponins fit in? -- 5. Using cardiac troponins in patients with acute myocardial infarction -- 6. What is a Type 2 myocardial infaction: how is it recognized and what should one do to establish that diagnosis? -- 7. Use of cardiac troponin in patients with heart failure -- 8. Elevated cTn in other acute situations such as atrial fibrillation, sepsis, respiratory failure, and gastrointestinal bleeding -- 9. Use of cTn for detection of more chronic disease states -- 10. Use of high-sensitive cTn assays for the evaluation of patients potentially at risk for cardiovascular disease -- 11. Other biomarkers in acute coronary syndrome -- 12. Newer lipid markers: apolipoprotein B, LDL particle concentration, and triglyceride-rich lipoproteins, when are they needed? -- Part II. Heart Failure -- 12. Natriuretic peptides: physiology for the clinician -- 14. Natriuretic peptides: basic analytic considerations -- 15. Natriuretic peptide use in screening in the community -- 16. Natriuretic peptide use in the emergency department -- 17. Heart failure: natriuretic peptide use in the hospital -- 18. Natriuretic peptide guided therapy in outpatient heart failure management -- 19. Caveats using natriuretic peptide levels -- 20. Gaps in our biomarker armamentarium: what novel biomarkers might be synergistic in patients with acute disease -- 21. Biomarkers in heart failure: ST2 -- 22. Biomarkers in heart failure: procalcitonin -- 23. Novel biomarkers in heart failure: adrenomedullin and proenkephalin -- 24. Biomarkers in specific disease states: cardio-oncology -- 25. Biomarkers of sarcopenia and mitochondrial dysfunction -- 26. Biomarkers in arrhythmias, sudden death, and device therapy -- 27. Biomarkers in cardio-renal dysfunction -- 28. Biomarkers in heart failure with preserved ejection fraction -- Index.